Cargando…
HPV vaccine: an overview of immune response, clinical protection, and new approaches for the future
Although long-term protection is a key-point in evaluating HPV-vaccine over time, there is currently inadequate information on the duration of HPV vaccine-induced immunity and on the mechanisms related to the activation of immune-memory. Longer-term surveillance in a vaccinated population is needed...
Autores principales: | Mariani, Luciano, Venuti, Aldo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2988719/ https://www.ncbi.nlm.nih.gov/pubmed/20979636 http://dx.doi.org/10.1186/1479-5876-8-105 |
Ejemplares similares
-
Immunotherapy of HPV-associated cancer: DNA/plant-derived vaccines and new orthotopic mouse models
por: Venuti, Aldo, et al.
Publicado: (2015) -
Beta HPV Type 15 Can Interfere With NF-κB Activity and Apoptosis in Human Keratinocytes
por: Paolini, Francesca, et al.
Publicado: (2020) -
Plant-Derived Natural Compounds in Genetic Vaccination and Therapy for HPV-Associated Cancers
por: Franconi, Rosella, et al.
Publicado: (2020) -
hrHPV E5 oncoprotein: immune evasion and related immunotherapies
por: de Freitas, Antonio Carlos, et al.
Publicado: (2017) -
HPV - immune response to infection and vaccination
por: Stanley, Margaret
Publicado: (2010)